Skip to main content
lexblog.com/lib/AV7CDFGXviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Andexxa Drug Recall December 2025 Due In Part To Safety Issue That Involves Blood Clots",
    "url": "https://www.lexblog.com/2025/12/15/andexxa-drug-recall-december-2025-due-in-part-to-safety-issue-that-involves-blood-clots/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-AV7CDFGX",
        "url": "https://www.lexblog.com/lib/AV7CDFGX/"
    },
    "datePublished": "2025-12-15T15:25:00-05:00",
    "dateModified": "2025-12-15T15:25:00-05:00",
    "author": {
        "@type": "Person",
        "name": "Tom Lamb"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Law Offices of Thomas J. Lamb, P.A."
    },
    "organizationScope": "at-publication",
    "isPartOf": "Drug Injury Watch",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "https://drug-injury.com/2025/12/15/andexxa-drug-recall-december-2025-safety-issue-blood-clots/",
    "sourceStability": "may-move"
}